News Center

Discover all of the trending news of the Ipsen Group


157 results

Event

Ipsen announces 50 posters to be presented at the 2019 TOXIN...

16 January 2019

TOXINS is a key conference for thought leaders – clinicians and researchers from academia and…

Event

JP Morgan Conference

09 January 2019

Click here to access the webcast.

Group

Ipsen: a story of transformation and growth

08 January 2019

On December 12th, at the closing ceremony of the prestigious French Finance congress, Financium, Aymeric Le Chatelier,…

Group

Ipsen Seasons greetings

31 December 2018

​A New Year has come​ and it's a wonderful time to reflect on what matters…

People

Ipsen France signs milestone Cancer and Employment Charter a...

28 November 2018

On Friday, 23rd November, Ipsen France celebrated a significant milestone by signing the Cancer & Employment Charter…

Group

Ipsen Group inaugurates new office in Singapore

31 October 2018

Ipsen, a leading  biopharmaceutical group  dedicated to improving lives through innovative medicines in specialty care (oncology , neuroscience and rare diseases) and…

Group

“How France can leverage its attributes and deliver on its f...

23 October 2018

Prior to joining Ipsen in 2016 as Chief Executive Officer, I lived in a number…

Oncology

How Ipsen is waging war on cancer by Bartek BEDNARZ

18 October 2018

10/18/2018 By Bartek BEDNARZ, Senior Vice-President, Oncology Franchise In the past 12 months we are…

Oncology

Spread the word: it is Liver Cancer Awareness Month

10 October 2018

October is Liver Cancer Awareness Month, a global initiative that aims to raise understanding of…

Innovation

Ipsen joins Biotechnology Innovation Organization (BIO) To A...

05 October 2018

Ipsen is delighted to join the Biotechnology Innovation Organization (BIO), the largest association of…

Group

Ipsen appoints Dr. Yan Moore as Senior Vice President, Head ...

28 September 2018

Paris (France), 27 September 2018 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointments of Dr.…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023